Lab equipment company BioSurplus names new CEO

BioSurplus, a lab equipment commerce company based out of San Diego, has named Bill VanDeWeghe president and CEO.            

VanDeWeghe is replacing Cinco Plumb, who will continue to serve as chairman of the board, according to a statement from the company.

VanDeWeghe, who brings more than 20 years of experience to the company, was the co-founder and CEO of mapping platform RippleNami. He also previously served as managing director at RA Capital Advisors and was a senior shareholder for Klinedinst PC law firm, both of which are based in San Diego.

"In the biotech and life science industry, BioSurplus has become the 'go-to' resource for preowned laboratory equipment," VanDeWeghe said. "Whether customers are buying equipment, selling surplus assets or closing entire facilities through our auction capabilities, the BioSurplus brand is synonymous with superb customer service. I am excited to build on this success and lead BioSurplus into the next chapter."

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”